| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |